Patents
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
07/2009
07/09/2009US20090176746 4'-{N'-[1-(3,4-dimethylphenyl)-3-methyl-5-oxo-1,5-dihydropyrazol-4-ylidene]hydrazino}-3'-hydroxybiphenyl-4-carboxylic acid; Promotes thrombopoiesis and megakaryocytopoiesis
07/09/2009US20090176307 Compounds, Compositions and Methods
07/09/2009US20090176111 multifunctional intercalant for the dispersion of the layered materials in a polymeric phase through an environmentally acceptable water or solvent-borne medium to form nanocomposites with desirable properties
07/09/2009US20090174324 Organic electroluminescent devices and metal complex compounds
07/09/2009CA2709923A1 A process for preparation of e-isomer of 1-(4-methylphenyl)-1-(2-pyridyl)-3-pyrrolidino prop-1-ene and acid addition salts thereof
07/08/2009EP2077262A1 Iminopyridine derivative and use thereof
07/08/2009EP2077114A1 Pharmaceutical preparation for treating fibromyalgia
07/08/2009EP2077109A1 Amide compound, salt thereof, and biofilm remover using them
07/08/2009EP2076261A2 Muscarinic receptor antagonists
07/08/2009EP1883470B1 Catalyst precursor for the production of olefins with an odd number of carbon atoms, process for its preparation and production method for such olefins
07/08/2009EP1664016B9 Therapeutic agents useful for treating pain
07/08/2009CN101479244A New urea derivatives and the application thereof
07/08/2009CN101479243A Glycine transporter-1 inhibitors
07/08/2009CN101479242A Process for making solid triphenylboron-pyridine
07/08/2009CN101479238A Amine derivative having npyy5 receptor antagonist activity
07/08/2009CN101475527A Method for preparing isonicotinic acid and pyrazinamide by non-catalytic hydrolyzing isonicotinonitrile in near-critical water medium
07/08/2009CN101475526A Carboxylic acid derivatives inhibiting the binding of integrins to receptors thereof
07/08/2009CN100510093C Method for preparing 3-heteroarylradical-3-hydroxy-propionic acid derivative
07/08/2009CN100509827C 电致发光材料 Electroluminescent material
07/08/2009CN100509790C Aryl- and heteroarylcarbonylpiperazines and their use for the treatment of benign and malignant oncoses
07/08/2009CN100509787C New pharmaceutically acceptable salt of pyritinol, and a preparation method thereof
07/08/2009CN100509786C Comprehensive process for tail gas in glyphosate production
07/08/2009CN100509783C Pheny(alkyl)carboxylic acid derivatives and dionic phenylalkylheterocyclic derivatives and their use as medicines with serum glucose and/or serum lipid lowering activity
07/08/2009CN100509774C Acylsulfonamides as inhibitors of steroid sulfatase
07/08/2009CN100509759C Novel alpha-oxygenated or alpha-thiolated carboxylic acid penethylamide derivatives
07/07/2009US7557216 Process for production of 5-chloro-2,4-dihydroxypyridine
07/07/2009US7557140 e.g. 3-[3-(2,4-Difluoro-phenylsulfamoyl)-phenyl]-N-hydroxy-acrylamide; histone deacetylase inhibitor; anticarcinogenic, antiinflammatory agent, autoimmune diseases; leukemia, atheriosclerosis, Alzheimer's disease, rheumatoid arthritis, psoriasis
07/07/2009US7557132 Compounds useful as pesticides
07/07/2009US7557129 Cyanopyridine derivatives useful in the treatment of cancer and other disorders
07/07/2009US7557125 Fab I inhibitors
07/07/2009CA2566684C Pharmaceutical nitrones
07/07/2009CA2539969C Process for the preparation of carboxylic acids of nitrogen-containing aromatic heterocyclic compounds
07/07/2009CA2438324C Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical
07/02/2009WO2009082347A1 Bis- (sulf onylamino) derivatives for use in therapy
07/02/2009WO2009081873A1 Organic material containing oligophenylene skeleton and light-emitting device using the same
07/02/2009WO2009081872A1 Method for producing 6-halogeno-3-arylpyridine derivative
07/02/2009WO2009081789A1 Sulfonyl substituted 6-membered ring derivative
07/02/2009WO2009081195A1 Carbamoyl compounds as dgat1 inhibitors 190
07/02/2009WO2009080637A1 Compounds which potentiate the ampa receptor and uses thereof in medicine
07/02/2009WO2009080203A2 Aminobenzamide derivatives as useful agents for controlling animal parasites
07/02/2009WO2009054004A3 Process for the preparation of sorafenib
07/02/2009US20090171096 Novel process for the preparation of roflumilast
07/02/2009US20090171095 Production method of heterocyclic mercapto compound
07/02/2009US20090170941 Pharmaceutical Compounds
07/02/2009US20090170908 Spiro compounds and pharmaceutical use thereof
07/02/2009US20090170895 S1p3 receptor antagonist
07/02/2009US20090170886 4-[(3-hydroxybenzyl)oxy]-2-(trifluoromethyl)benzonitrile; selective androgen receptor modulators; decrease excess sebum secretions; stimulants of hair growth at higher rates of cosmetically acceptable hair growth in patients with alopecia; acne; skin disorders; prostate cancer
07/02/2009US20090170883 3-arylphenyl sulfide derivative and insecticide and miticide
07/02/2009US20090170881 New inhibitors of histone deacetylase
07/02/2009US20090170850 Cycloalkyl derivatives of 3-hydroxy-4-pyridinones
07/02/2009US20090170836 New inhibitors of histone deacetylase
07/02/2009US20090170824 Diarylsulfones as 5-HT2A Antagonists
07/02/2009CA2710120A1 Aminobenzamide derivatives as useful agents for controlling animal parasites
07/02/2009CA2709510A1 Bis-(sulfonylamino) derivatives for use in therapy
07/02/2009CA2707660A1 Carbamoyl compounds as dgat1 inhibitors 190
07/02/2009CA2707447A1 Sulfonyl-substituted 6-membered ring derivative
07/01/2009EP2074103A1 6-phenylpyrimidinones as pim modulators
07/01/2009EP2074097A2 Compounds for treating proliferative disorders
07/01/2009EP2074096A1 3-pyridinecarboxamide and 2-pyrazinecarboxamide derivatives as hdl-cholesterol raising agents
07/01/2009EP2074095A2 Process for the preparation of imatinib and intermediates thereof
07/01/2009EP2074084A1 Compounds which modulate the cb2 receptor
07/01/2009EP2074083A1 New sulfonamide derivatives as bradykinin antagonists
07/01/2009EP1915344B1 Cyanopyridine pesticides
07/01/2009EP1883407A4 Compositions and methods for treatment for neoplasms
07/01/2009EP1868999B1 Pyridine-3-carboxamide derivatives as cb1 inverse agonists
07/01/2009EP1858852B1 Heteroarylsulfonyl stilbenes as 5-ht2a antagonists
07/01/2009EP1756043B1 Ortho substituted aryl or heteroaryl amide compounds
07/01/2009EP1537075B1 Diarylurea derivatives and their use as chloride channel blockers
07/01/2009EP1423362B1 New mandelic acid derivative and its use as thrombin inhibitor
07/01/2009EP1380342B1 Complex catalyst, process for producing the complex catalyst, and process for producing alcohol derivative with the complex catalyst
07/01/2009EP1226127B1 Substituted phenyl sulfamoyl carboxamides
07/01/2009CN101472895A Pest control agent containing novel pyridyl-methanamine derivative or salt thereof
07/01/2009CN101472894A Phenylpentadienoyl derivatives and their use as PAR 1 antagonists
07/01/2009CN101472893A Polymorph forms of (2S)-(4E)-N-methyl-5- (3-isopropoxypyridin) yl]-4-penten-2-amine for the treatment of central nervous system disorders
07/01/2009CN101468965A Biaryl substituted 6-membered heterocyles as sodium channel blockers
07/01/2009CN100506807C Amide derivatives as GK activators
07/01/2009CN100506801C Inhibitors of glycogen synthase kinase 3
07/01/2009CN100506788C Arylalkylcarbamate derivatives production and use thereof in therapy
06/2009
06/30/2009US7554000 Reacting an arylhydrazine, hydrogen peroxide and an aryl compound using a catalytic metal of Group 5,6,7 or 8 or an oxide of a metal of Group 5,6,7 or 8 obtained by reacting the given metal with hydrogen peroxide; improved yield; quaternary amine as phase transfer agent; water solvent and by-product
06/30/2009US7553988 Method for producing coupling compound
06/30/2009US7553972 Benzamide inhibitors of the P2X7 receptor
06/30/2009US7553971 Aryl aniline β2 adrenergic receptor agonists
06/30/2009US7553970 Process for preparing 3-heteroaryl-3-hydroxypropanoic acid derivatives
06/30/2009US7553966 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
06/30/2009US7553964 Useful in treating conditions or disorders prevented by or ameliorated by histamine-3 receptor ligands; for example, 5-{4-[3-({2R}-2-methyl-pyrrolidin-1-yl)-cis-cyclobutyl]-phenyl}-pyrimidine
06/30/2009US7553959 comprises cyanine dyes, xanthene dyes, porphyrin dyes, coumarin dyes or composite dyes for use in labeling nucleic acids or proteins in assay, and as diagnostic aid in genomics/proteomics
06/30/2009US7553877 Use of 2-hydroxy-1,2,3,4,4a,9,10,10a-octahydrophenanthrene compounds glucocorticoid receptor agonists to treat certain inflammatory conditions such as arthritis, asthma
06/30/2009US7553872 Compounds and compositions for delivering active agents
06/30/2009US7553830 Compositions for the delivery of negatively charged molecules
06/30/2009US7553798 Heterocyclic carboxamides with microbiocidal activity
06/30/2009CA2406088C Novel phenyl-propargylether derivatives
06/30/2009CA2307111C Novel pyridazine derivatives and drugs containing the same as the active ingredient
06/25/2009WO2009079597A1 Piperazinyl derivatives useful as modulators of the neuropeptide y2 receptor
06/25/2009WO2009079593A1 Piperazinyl derivatives useful as modulators of the neuropeptide y2 receptor
06/25/2009WO2009078934A1 Mineralocorticoid receptor modulators
06/25/2009WO2009078746A1 Substituted 3 -hydroxypyridines and pharmaceutical compositions thereof
06/25/2009WO2009077392A1 Azomethine direct dyes or reduced precursors of these dyes obtained from 2-amino-3-hydroxypyridine, and hair dyeing process using these dyes and precursors
06/25/2009WO2009077367A1 Novel pyrazole-substituted arylamides
06/25/2009WO2009077068A1 Ester derivatives as phosphodiesterase inhibitors
06/25/2009WO2009076747A1 Viral polymerase inhibitors